The ADAA 2018 Conference brought more than 1,400 clinicians and researchers from across the United States and around the world together in Washington, DC to share, network, collaborate and learn about treatment-resistant anxiety, depression, and related disorders. It was four days of unparalleled educational content. Conference attendees left feeling energized, more connected to their peers and better able to integrate research, practice and community.
Many thanks to the 2018 Conference Committee chaired by Sanjay Mathew. The committee’s dedication and hard work helped ensure a wonderfully successful event.
The 2018 ADAA Conference Hit Record Highs with more than 1,400 US and international attendees, more than 180 sessions, more than 350 poster presentations, 15 sponsors and 40 exhibitors.
The opening session featured an overview of ADAA’s mission and accomplishments presented by ADAA President Beth Salcedo. The 2018 Donald F. Klein; Andrew Burns; Alies Muskin Career Development Leadership Program; and Member Recognition awardees and participants were honored.) The opening keynote was presented by Joshua Gordon, MD, PhD on the “Update from the NIMH”. The Jerilyn Ross Lecture was presented by Maurizio Fava, MD focused on “Pharmacological Strategies in the Treatment of Resistant Depression (TRD): The Past, The Present, and The Future”.
The opening evening reception was sponsored by Beck Institute for Cognitive Behavior Therapy.
Session highlights included a full-day workshop with Dr. Reid Wilson, a Saturday Plenary focused on the Opioid Criss, Master Clinician sessions and Timely Topic sessions, the 21st Annual Scientific Symposium, and more than 180 sessions of a broad range of clinical and research topics.
There were also two poster sessions where young professionals presented their current research.
Special conference events included a first time attendee breakfast, SIG breakfasts, networking breakfasts and coffee breaks with the exhibitors, a film screening and discussion of "Unstuck: An OCD Kids movie."
#ADAA2018 In The News
04/18/2018 Lurasidone Appears Safe at 28 Weeks in Kids With Bipolar Depression, Medscape.com
04/17/2018 'Fear of Fear' May Influence OCD, PTSD Outcomes, Medscape.com, Allison Baier, BS, Teresa M. Leyro, PhD, and Lillian Reuman, MA
04/12/2018 Ketamine: Key Predictor of Treatment Response for MDD Identified, Medscape.com, Sanjay Mathew, MD, and Samuel Wilkinson, MD
04/11/2018 Array of Markers Collectively Predicts MDD Treatment Response, Medscape.com, Edward Craighead, PhD, ABPP and Charles B. Nemeroff, MD, PhD
04/10/2018 Virtual Reality Therapy Gains Ground for PTSD, Other Disorders, Medscape.com, Laura Loucks, PhD, Melissa Peskin, PhD, and Barbara Rothbaum, PhD, ABPP
04/10/2018 Few Psychiatrists Recommend Exercise for Anxiety Disorders, Medscape.com, Samantha G. Farris, PhD, Julia Mason, MA, Dawn C. Roberts, PhD, Beth Salcedo, MD
We invite you to view Conference photos by clicking here. You don’t have to be a Facebook member to view/download the photos. If you would like a high resolution copy of any photo please email Lise at email@example.com.
Save the Date for #ADAA2019